Craig Donald BurrellBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4124 (Published 12 August 2010) Cite this as: BMJ 2010;341:c4124
- Catherine Burrell
Craig Donald Burrell, physician, Sandoz executive, and past president of the New York Academy of Sciences, died on 20 November 2009 at the Lutheran Medical Centre, Brooklyn, from a massive cerebral haemorrhage. He had travelled to celebrate Thanksgiving with his family.
His career in America began in January 1960, when he was appointed assistant professor of medicine and medicine in psychiatry at Cornell University Medical School in New York City. He was in charge of the Metabolic Unit of the Payne Whitney Psychiatric Clinic, having previously, with a hospital physicist, set up the first radioiodine diagnostic and research unit in Wales.
1961 marked the beginning of a 25 year employment with Sandoz (first Sandoz Pharmaceuticals and then Sandoz Inc). Dr Burrell served Sandoz as medical director (where he liaised with the Food and Drug Administration on clinical trials, including the removal of LSD from clinical research), vice president of medical affairs, and, finally, as vice president of external affairs. He sat on the steering committee of the Pharmaceutical Manufacturers Association, and was its representative to the board of trustees of the American Association of Laboratory Animal Care, which he served as treasurer and as a member of its executive committee.
He was active as a spokesman on issues ranging from patient package inserts to ethics in research. He was responsible for ensuring that Sandoz did not use prisoners for medical research, and he testified before the National Commission on Protection …